PROKIDNEY news, videos and press releases
For more news please use our advanced search feature.
PROKIDNEY - More news...
PROKIDNEY - More news...
- ProKidney Reports Full Year 2024 Financial Results and Business Highlights
- ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference
- ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting
- ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference
- ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2024
- ProKidney to Participate in the UBS Virtual Organ Restoration Day
- ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S.
- ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- ProKidney Reports Business Updates and Second Quarter 2024 Financial Results
- ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters’ Option
- ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
- ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
- ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
- ProKidney to Participate in the Jefferies Global Healthcare Conference
- ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
- ProKidney Reports Business Updates and First Quarter 2024 Financial Results
- ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
- ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
- ProKidney to Participate in Jefferies Biotech on the Bay Summit
- ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer
- ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference
- ProKidney Reports Third Quarter Financial Results
- ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates
- ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023
- ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference
- ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights
- ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC
- ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization
- ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC
